Method of producing pharmaceuticals or food supplements comprising pigmented polymer coatings

Modified release oral pharmaceutical composition

Pharmaceutical composition containing platinum complex as active substance and method of manufacturing thereof

Stable lipophilic emulsions for acrylic coating and method of making

Stable pharmaceutical formulations of benzimidazole compounds

Pharmaceutical tablets containing tibolone and a coating

Extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof

4-phenylbutyric acid controlled-release formulations for therapeutic use

Paroxetine formulations

Modified release compositions of milnacipran

Composition comprising a benzimidazole and process for its manufacture

Disintegrant assisted controlled release technology

Extended release venlafaxine besylate tablets

Pharmaceutical dosage forms including rasagiline

Controlled release preparation

Delayed release formulations of 6-mercaptopurine

Tablet for pulsed delivery

Pulsatile release compositions of milnacipran

Oral sustained release formulation of tedisamil with gastric retention properties

Immediate release formulations of 1-aminocyclohexane compounds, memantine and neramexane

Methods for coating substrates for pharmaceutical uses with a mixture of two film-forming coating agents

Pravastatin pharmaceutical formulations and methods of their use

Method for producing coated pharmaceuticals and food supplements with concentration gradients in the coating thereof

Preparation of stable paroxetine HC1 ER tablets using a melt granulation process

Omeprazole dosage form

Dosage forms of bisphosphonates

Pharmaceutical compositions for the coordinated delivery of NSAIDs

Dosing methods for beta-D-2',3'-dideoxy-2',3'-didehydro-5-fluorocytidine antiviral therapy

Modified-release tablet of bupropion hydrochloride

Controlled release opioid analgesic formulation

Venlafaxine compositions in the form of microtablets

Methods and composition of extended delivery of water insoluble drugs

Methods and compositions for improving drug safety

Method of treating amyloid beta precursor disorders

Controlled release formulations using intelligent polymers

Granulate or powder for producing coating or binding agents for medicaments

Tolperisone-containing pharmaceutical preparation with controllable active-substance release for oral administration

Aqueous polymer dispersions based on alkyl (meth)acrylates

Aldosterone antagonist compositions for release during aldosterone acrophase

Once daily dosage forms of trospium

Galantamine formulations

Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures

Lansoprazole microtablets

Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures

Carvedilol free base, salts, anhydrous forms or solvates thereof, corresponding pharmaceutical compositions, controlled release formulations, and treatment or delivery methods

Preparation composition containing acid-unstable physiologically active compound, and process for producing same

Drug delivery system for averting pharmacokinetic drug interaction and method thereof

Quetiapine formulations

Sustained release ranolazine formulations

Dosage form and method for producing the same

Method of treatment for improved bioavailability

Pharmaceutical dosage forms comprising tablet core having a tensile strength below 38 n/sqcm and a coating to protect the soft core

Galantamine formulations

Pharmaceutical formulations of amyloid inhibiting compounds

pH sensitive polymer and process for preparation thereof

Novel composition and use

Pharmaceutical formulations for carrier-mediated transport statins and uses thereof

Extended release alpha-2 agonist pharmaceutical dosage forms

Pharmaceutical composition for oral use with improved absorption

Increasing cerebral bioavailability of drugs

Zero order controlled drug delivery system

Modafinil modified release pharmaceutical compositions

Decongestant and expectorant tablets

Treatment of gastroparesis and nonulcer dyspepsia with GABAB agonists

Formulations and methods of treating inflammatory bowel disease

Film coating

Oral pharmaceutical formulation containing ibandronate

Oral 2-methyl-thieno-benzodiazepine formulation

Tablet with aqueous-based sustained release coating

Pharmaceutical dosage form and method for the production thereof

Stable lipophilic emulsions for acrylic coating and method of making

Sustained release ranolazine formulations

Modified release venlafaxine hydrochloride tablets

Antibiotic product, use and formulation thereof

Osmotically-driven fluid dispenser

Controlled release pharmaceutical formulation containing venlafaxine

Modified release composition comprising a short-acting hypnotic for treatment of sleep disorders

Pharmaceutical formulatins useful for inhibiting acid secretion and methods for making and using them

Novel formulations and method of treatment

Oral pharmaceutical formulations of acid-labile active ingredients and process for making same

Modified calcium phosphate excipient

Pharmaceutical compositions for the oral administration of heparin or derivatives thereof

Enteric formulations of proanthocyanidin polymer antidiarrheal compositions

Liposome drug delivery

Embolization protection system for vascular procedures

Use of methylnaltrexone to treat irritable bowel syndrome

Sustained-release, oral pharmaceutical formulations and methods of making and using same

Pharmaceutical composition for modified release

Coated tablets for pH-dependent release of benzgalantamine

Enteric coated tiopronin tablet

Release stable mesalamine dosage forms

Drug formulations having reduced abuse potential